Xiaomi Fund and iHealth Labs Invest in Beijing Qiji Chuangtan Phase II Venture Capital Center
3 week ago / Read about 0 minute
Author:小编   

Recently, Beijing Qiji Chuangtan Phase II Venture Capital Center (Limited Partnership) has undergone significant industrial and commercial transformations, welcoming new shareholders such as Xiaomi's fund, Hanxing Venture Capital Co., Ltd., and Tianjin iHealth Labs Medical Electronics Co., Ltd. Established in 2022 with a registered capital of 906 million Chinese yuan, this enterprise primarily focuses on equity investments, investment management, and asset management activities through private equity funds.